| Date Filed | Type | Description |
| 06/16/2023 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 12,000 shares
@ $0
Granted 36,000 options to buy
@ $5.31, valued at
$191.2k
|
|
| 05/30/2023 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 9,288 shares
@ $0
Granted 33,175 options to buy
@ $3.23, valued at
$107.2k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on HARROW HEALTH, INC.|
Txns:
| Sold 3,900 shares
@ $10.04, valued at
$39.2k
|
|
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2020 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 32,127 shares
@ $0 |
|
| 09/17/2020 |
3
| LINDSTROM RICHARD L MD (Director) has filed a Form 3 on LENSAR, Inc. |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on HARROW HEALTH, INC.|
Txns:
| Granted 17,006 options to buy
@ $0 |
|
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2019 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 18,000 options to buy
@ $3.9, valued at
$70.2k
|
|
| 03/14/2019 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Bought 56,441 shares
@ $4.33, valued at
$244.4k
|
|
| 07/02/2018 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.|
Txns:
| Granted 34,091 options to buy
@ $0 |
|
| 06/15/2018 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 18,000 options to buy
@ $8.14, valued at
$146.5k
|
|
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2016 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on TearLab Corp|
Txns:
| Granted 15,000 options to buy
@ $0.69, valued at
$10.4k
|
|
| 06/14/2016 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.|
Txns:
| Granted 12,690 options to buy
@ $0 |
|
| 06/03/2016 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 13,500 options to buy
@ $12.05, valued at
$162.7k
|
|
| 05/11/2016 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on TearLab Corp|
Txns:
| Bought 133,332 shares
@ $0
Bought 66,666 warrants
@ $1.125, valued at
$75k
|
|
| 08/12/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2015 |
4
| LINDSTROM RICHARD L MD (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC|
Txns:
| Granted 5,681 options to buy
@ $22.54, valued at
$128k
|
|
|